OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Lin on the Treatment Landscape in HER2+ Metastatic Breast Cancer

July 16th 2020

Nancy U. Lin, MD, discusses the treatment landscape in HER2-positive metastatic breast cancer.

Dr. Czerniecki on Treatment Options for Patients With HER2+ Brain Metastases

July 15th 2020

Brian Czerniecki, MD, PhD, discusses treatment options for patients with HER2-positive breast cancer who have brain metastases.

Dr. Daver on the Utility of Maintenance Therapy in AML

July 15th 2020

Naval G. Daver, MD, discusses the utility of maintenance chemotherapy in acute myeloid leukemia.

Dr. Slomovitz on the Role of Surgery in Endometrial Cancer

July 15th 2020

Brian M. Slomovitz, MD, discusses the role of surgery in women with endometrial cancer.

Dr. Ghia on the Shift From Chemotherapy to Novel Agents in CLL

July 15th 2020

Paolo Ghia, MD, PhD, discusses how use the of chemotherapy is decreasing in favor of novel agents in chronic lymphocytic leukemia.

Dr. Ahmed on Key Strategies for Managing Breast Cancer Brain Metastases

July 15th 2020

Kamran A. Ahmed, MD, discusses key strategies to manage patients with breast cancer and brain metastases.

Dr. Luke on Future Research With T-Cell Therapy in Melanoma

July 15th 2020

Jason J. Luke, MD, FACP, discusses the future of T-cell therapy in melanoma.

Dr. Davids on the Potential Utility of Ibrutinib/Umbralisib in MCL and CLL

July 15th 2020

Matthew S. Davids, MD, MMSc, discusses the potential utility of ibrutinib in combination with umbralisib in patients with mantle cell lymphoma or relapsed/refractory chronic lymphocytic leukemia.

Dr. Bach Discusses Ongoing Research With ctDNA in CRC

July 15th 2020

Sander Bach, MD, PhD, discusses ongoing research with circulating tumor DNA in colorectal cancer.

Dr. Rana on Using Age at Diagnosis to Guide the Utility of Genetic Testing in Prostate Cancer

July 14th 2020

Huma Q. Rana, MD, MPH, discusses the use of age at diagnosis to guide the utility of genetic testing in men with prostate cancer.

Dr. Treon on the Evolution of BTK Inhibitors in Waldenström Macroglobulinemia

July 14th 2020

Steven P. Treon, MD, PhD, discusses the role of BTK inhibitors in Waldenström macroglobulinemia.

Dr. Maddocks on the Role of Zanubrutinib in B-Cell Malignancies

July 14th 2020

Kami J. Maddocks, MD, discusses the role of zanubrutinib in B-cell malignancies.

Dr. Raje on the Design of the ENDURANCE Trial in Newly Diagnosed Multiple Myeloma

July 14th 2020

Noopur S. Raje, MD, discusses the design of the randomized phase 3 ENDURANCE trial in newly diagnosed multiple myeloma.

Dr. Bach on the Results of a Systematic Review of ctDNA in CRC

July 14th 2020

Sander Bach, MD, PhD, discusses the results of a systematic review of circulating tumor DNA in colorectal cancer.

Dr. Leslie on the Current Frontline Treatment Landscape in MCL

July 14th 2020

Lori A. Leslie, MD, discusses the current frontline treatment landscape in mantle cell lymphoma.

Dr. Martin on the Frontline Treatment Landscape of MCL

July 13th 2020

Peter Martin, MD, discusses the frontline treatment landscape of mantle cell lymphoma.

Dr. Verstovsek on the Rationale Behind Treating Myelofibrosis With CPI-0610/Ruxolitinib

July 13th 2020

Srdan Verstovsek, MD, PhD, discusses research efforts being made with CPI-0610 in the treatment of patients with myelofibrosis.

Dr. Costa on the Design of a First-in-Human Study With CC-93269 in R/R Myeloma

July 13th 2020

Luciano J. Costa, MD, PhD, discusses the design of a phase 1 first-in-human study with CC-93269 in relapsed/refractory multiple myeloma.

Dr. Stenzl on the Safety Profile of Enzalutamide/ADT in mHSPC

July 13th 2020

Arnulf Stenzl, MD, discusses the safety profile of enzalutamide in combination with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.

Dr. Ahn on Left- Versus Right-Sided Tumors in CRC

July 13th 2020

Daniel H. Ahn, DO, discusses left- versus right-sided tumors in colorectal cancer.